Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SLC18A3 | Q16572 | 6/20 | 0.44 |
| ▸ | FUCA1 | P04066 | 2/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6042627 | 0.87 | ALDH1A1 (0.43) | ALDH1A1SLC18A3FUCA1ACHE | |
| SCHEMBL30994643 | 0.80 | ALDH1A1 (0.54) | ALDH1A1SLC18A3FUCA1ACHE | |
| SCHEMBL1869073 | 0.80 | ACHE (0.39) | ALDH1A1ACHE | |
| SCHEMBL7226356 | 0.76 | ALDH1A1 (0.55) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL5157969 | 0.74 | FUCA1 (0.66) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL5157349 | 0.74 | FUCA1 (0.66) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL7226969 | 0.73 | ACHE (0.60) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL10267804 | 0.73 | ACHE (0.60) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL765298 | 0.73 | ACHE (0.60) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 | |
| SCHEMBL914717 | 0.73 | ACHE (0.60) | ALDH1A1SLC18A3FUCA1ACHESIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100324030-A1 | 5-Quinoline derivatives having an anti-bacterial activity | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324030-A1 | 5-Quinoline derivatives having an anti-bacterial activity | TOP2A, TOP1, TOP2B | ALDH1A1 3016/4885SLC18A3 4224/4885FUCA1 2749/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.